WO2023011994 - PROCESS FOR THE CATALYTIC GLYCOSYLATION OF ARENES
National phase entry:
Publication Number
WO/2023/011994
Publication Date
09.02.2023
International Application No.
PCT/EP2022/070996
International Filing Date
26.07.2022
Title **
[English]
PROCESS FOR THE CATALYTIC GLYCOSYLATION OF ARENES
[French]
PROCÉDÉ DE GLYCOSYLATION CATALYTIQUE D'ARÈNES
Applicants **
STUDIENGESELLSCHAFT KOHLE gGmbH
Kaiser-Wilhelm-Platz 1
45470 Mülheim, DE
Inventors
LIST, Benjamin
Lembkestrasse 30
45470 Mülheim an der Ruhr, DE
OBRADORS, Carla
2000 Antwerp, BE
MITSCHKE, Benjamin
45468 Mülheim an der Ruhr, DE
AUKLAND, Miles
45468 Mülheim an der Ruhr, DE
Priority Data
21189383.9
03.08.2021
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 973 | |
| EPO | Filing, Examination | 4598 | |
| Japan | Filing | 591 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 2710 |
Total: 9447 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention refers to a process for the catalytic glycosylation of arenes which allows, amongst others, the expeditious synthesis of the nucleoside analogue GS-441524 of the antiviral prodrug remdesivir.[French]
La présente invention concerne un procédé de glycosylation catalytique d'arènes qui permet, entre autres, la synthèse rapide de l'analogue nucléosidique GS-441524 du promédicament antiviral remdesivir.